Arcus Biosciences (RCUS) SEC Filings & 10K Form

$15.51
+0.83 (+5.65%)
(As of 04/23/2024 ET)

Recent Arcus Biosciences SEC Filings

DateFilerForm TypeView
03/29/2024
3:20 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
3:19 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:30 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
6:55 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:55 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:49 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4/A
02/21/2024
3:53 PM
Arcus Biosciences (Filer)
Form S-3ASR
02/21/2024
3:16 PM
Arcus Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
7:35 AM
Arcus Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G
02/07/2024
5:58 PM
Arcus Biosciences (Issuer)
Mercier Johanna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2024
3:58 PM
Arcus Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SC 13D/A
01/31/2024
4:00 PM
Arcus Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:17 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
6:38 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:40 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:40 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
6:33 AM
Arcus Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
10:52 AM
Arcus Biosciences (Subject)
Form SC 13G/A
01/04/2024
4:22 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:23 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:44 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:47 PM
Arcus Biosciences (Subject)
Goeltz II Robert C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
4:17 PM
Arcus Biosciences (Subject)
Jaen Juan C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
3:20 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
3:06 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:28 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
3:35 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:16 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
3:46 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:47 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
At first glance, this chart looks like nonsense… (Ad)

We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”

But if you want the stock with “Hotspot Dates” hitting NEXT WEEK…
09/15/2023
3:53 PM
Arcus Biosciences (Subject)
Nuyten Dimitry SA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:49 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2023
7:08 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
7:13 AM
Arcus Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2023
3:15 PM
Arcus Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
3:15 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
8:38 AM
Arcus Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SC 13D/A
06/30/2023
2:12 PM
Arcus Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
7:25 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
3:36 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:07 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2023
7:16 PM
Arcus Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:16 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:17 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:01 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:03 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:05 PM
Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:06 PM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:08 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:09 PM
Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:11 PM
Arcus Biosciences (Issuer)
Lambert Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:12 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:14 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:19 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:12 PM
Arcus Biosciences (Subject)
ROSEN TERRY J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
3:15 PM
Arcus Biosciences (Subject)
Jaen Juan C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
3:18 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
1:17 PM
Arcus Biosciences (Subject)
Goeltz II Robert C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
7:25 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
7:34 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2023
3:20 PM
Arcus Biosciences (Filer)
Form ARS
04/25/2023
3:20 PM
Arcus Biosciences (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:RCUS) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners